Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships

ANDERNACH, GERMANY - Newsaktuell - 14 January 2025 - LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies.



LTS
LTS' proprietary dissolvable microneedle array patch technology with mRNA vaccines aims for the development of next generation vaccine technologies. Source: LTS LOHMANN Therapie-Systeme AG

The Patch Forward Prize, part of the Project NextGen initiative led by BARDA, aims to accelerate next-generation vaccine technologies. By fostering partnerships between vaccine developers and delivery platform innovators, the competition drives progress from concept to clinical stages, paving the way for transformative advancements in global health. Each of the prizes announced today represents an award of US$ 2 million, that will be shared between LTS and its partners.

The awarded projects bring together LTS's proprietary dissolvable Microneedle Array Patch (MAP) technology with mRNA vaccines from two partners, BioNet, a biotech manufacturer specializing in genetically engineered vaccines and PopVax, an Indian full-stack biotechnology company developing broadly-protective mRNA vaccines using machine learning-enabled computational protein design.

Both projects aim to address critical challenges in vaccine stability, delivery, and adaptability, with the potential to improve patient access and compliance. The focus will be on seasonal influenza vaccines, with the ability to pivot to pandemic strains if necessary.

BioNet's approach tackles the ongoing challenge of influenza strain variability by developing a trivalent seasonal influenza mRNA vaccine (mIV3) that targets conserved regions of the hemagglutinin (HA) and neuraminidase (NA) proteins from dominant H1N1, H3N2, and B influenza viruses. These mRNA constructs are carefully selected to elicit broad protective immune responses against seasonal influenza.

PopVax is leading the effort to develop a seasonal influenza vaccine built on their novel mRNA-encoded immunogen display architecture and LNP platform. PopVax's immunogen design and display approach boosts the elicited strain-specific antibody response by as much as 250x in mice in comparison with a leading approved influenza vaccine, leading to significantly lower dosage requirements. This approach also elicits a broader immune response, including robust antibody titer against pandemic H5N1 influenza, a rising threat in the United States, despite not encoding an H5N1-specific immunogen.

LTS CEO Bas van Buijtenen commented: "As a front-runner in drug delivery, we care passionately about solutions that provide better outcomes and better patient experience. We are grateful and proud that Barda's Patch Forward prize provides an opportunity to BioNet, PopVax and LTS to create a breakthrough in vaccine administration. We look forward to delivering on the promise of the combination of our technologies through our joint programs."

"LTS Microneedle-Array-Patch (Map)-Program is proud to have received those 2 awards together with our partners PopVax and BioNet, with their innovative mRNA technologies", added Dr. Frank Theobald, Head of MAP Program at LTS. "The BARDA Patch Forward Price allows combination of 2 breakthrough technologies to be better prepared for the next pandemics to come. The financial support from BARDA will help to advance the MAP technology towards commercialization addressing an unmet medical need and offering the opportunity for self-administration as well as the opportunity for lowering the cold-chain requirements for mRNA."

- Picture is available at AP -


Hashtag: #FEV

The issuer is solely responsible for the content of this announcement.

About LTS

We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") as well as wearable drug delivery devices ("OBDS"). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS's innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Microneedle Array Patches ("MAP") for the transdermal delivery of small and large molecules, biological actives and vaccines. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. Founded in 1984, LTS operates today from four sites: in Andernach, Germany, West Caldwell, NJ, USA, St. Paul, MN, USA and Netanya, Israel. LTS has also a representative office in Shanghai, China.

News from Asia

Puffin Secure Browser is back with a security-first focus built on its proven cloud architecture

After more than a decade developing cloud-based browser technology, CloudMosa is reintroducing Puffin Secure Browser with a security-first architecture at its core to help address AI-driven cyberat...

Singapore’s iCOMPASS Launches KY-AI to Help Financial Institutions Govern Autonomous AI Under New MAS Guidelines

Singapore-developed platform brings AI inventory, risk assessment, approvals, testing and ongoing oversight into a structured governance process.SINGAPORE - Media OutReach Newswire - 18 November 2...

The Longines Hong Kong International Horse Show and The Hong Kong Jockey Club Champion the Next Generation Through the Asia Pacific Youth Challenge

Asia Pacific’s rising star riders set their sights on the January 2027 Show, alongside family-focused ways for young fans to experience equestrian sport. Tickets are now available via HK Ticketin...

Singapore Becomes Launchpad for Lean Deep-Tech Teams Going Global Within Months, Osome Data Shows

SINGAPORE - Media OutReach Newswire - 18 November 2026 - As the Singapore FinTech Festival (SFF) returns from 18 to 20 November to examine how finance is being rewired, Osome, the AI company manag...

New WEIKEN Showroom at Paya Lebar Opens Its Doors with an Exclusive Homeowners Launch Event

SINGAPORE – Media OutReach Newswire – 18 November 2026 – Weiken @ AZ Paya Lebar, the brand's newest showroom at 140 Paya Lebar Road, officially opened on 13 November 2026, giving Singapore homeow...

Jackson Wang’s Wax Figure Arrives at Madame Tussauds Singapore for a Limited-Time Experience

Step into Hallyu: Enter Your Bias's World. No Screen. No Barrier.SINGAPORE - Media OutReach Newswire - 18 November 2026 - Get ready to step into the world of Hallyu! Madame Tussauds Singapore invi...

China’s Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award

PARIS, FRANCE – Media OutReach Newswire – 18 November 2026 – From 14 to 15 October 2026, the 2026 INPD Award was held at the Carrousel du Louvre in Paris, France...

Allocator One Launches with $100M+ Venture Capital Fund of Funds, with 17 Unicorns in Portfolio

Allocator One emerges from stealth; Flagship Fund I's underlying fund investments report 11% DPI; the firm expands across Asia-Pacific from its Singapore hub and hosts Alpha Summit Asia on 18 Novem...

Arrow Electronics to showcase technologies and engineering capabilities for intelligent edge AI systems at EdgeTech+

YOKOHAMA, JAPAN – Media OutReach Newswire – 18 November 2026 – Arrow Electronics, a global provider of technology solutions, is showcasing technologies and engineering capabilities for intelligen...

TCMA Advances ASEAN Cement Decarbonization with 14.4 Mt. of CO₂ Reductions

Building Global Partnerships and Technology Connections towards the 27th AFCM Technical Symposium & Exhibition 2027BANGKOK, THAILAND – Media OutReach Newswire – 18 November 2026 – Thai Cement...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...